This paper describes updated methods for NASA to assess and mitigate health and performance risks for human spaceflight.
NPJ Microgravity · 6 authors, 5 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This paper describes updated methods for NASA to assess and mitigate health and performance risks for human spaceflight.
The process includes defined risk impact categories for in-mission, flight recertification, and long-term health outcomes. A revised Level of Evidence (LoE) scoring system moves from correlative to causative criteria to evaluate diverse evidence types. The framework uses causal diagramming via directed acyclic graphs to communicate risk pathways. The authors note that the process is designed to evolve with changing mission parameters and that its detailed nature may not be directly transferable to commercial entities without adaptation.